Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/10553
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | restrictedAccess | - |
dc.contributor.author | Jurisic, Vladimir | - |
dc.contributor.author | Čolović N. | - |
dc.contributor.author | Terzić D. | - |
dc.contributor.author | Djordjevic V. | - |
dc.contributor.author | Colovic, Mirjana | - |
dc.date.accessioned | 2021-04-20T16:02:59Z | - |
dc.date.available | 2021-04-20T16:02:59Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 0344-0338 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/10553 | - |
dc.description.abstract | A 56-year-old male with chronic idiopathic myelofibrosis and cytogenetic finding of 20q- after a period of 10 months developed acute Philadelphia-positive lymphoblastic leukemia. Immunophenotyping of peripheral blood by flow cytometry showed HLA-DR, CD34, CD19, CD22, CD10, CD33, and CD11b positivity. Cytogenetic analysis revealed the presence of 20q- and Philadelphia chromosome t(9;22)(q34:q11) at the time of disease transformation to ALL. The JAK2V617F mutation was not found. This is a very rare case of simultaneous presence of two cytogenetics abnormalities and evolution of primary idiopathic myelofibrosis to Philadelphia-positive acute lymphoblastic leukemia. © 2012 Elsevier GmbH. | - |
dc.rights | info:eu-repo/semantics/restrictedAccess | - |
dc.source | Pathology Research and Practice | - |
dc.title | Transformation of primary myelofibrosis with 20q- in Philadelphia-positive acute lymphoblastic leukemia: Case report and review of literature | - |
dc.type | article | - |
dc.identifier.doi | 10.1016/j.prp.2012.04.007 | - |
dc.identifier.scopus | 2-s2.0-84863815856 | - |
Appears in Collections: | Faculty of Medical Sciences, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.86 kB | Adobe PDF | ![]() View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.